Washington D.C., USA, 22-27 July 2012www.aids2012.org Treatment as Prevention: It is complex: Let us work on it Kenneth H. Mayer Fenway Health Beth Israel.

Slides:



Advertisements
Similar presentations
Scaling up HIV services for women and children achievements and challenges e-lluminate session e-lluminate session Yves Souteyrand 2 March 2010.
Advertisements

No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Coordinating Care Across Funded Providers to Support Retenion in Care: The In+Care Campaign in RI. Aadia Rana, MD Assistant Professor of Medicine Miriam.
Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
The HIV Engagement in Care Cascade Edward Gardner, MD Associate Professor of Medicine Denver Public Health University of Colorado Denver.
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
TasP is not enough Stipulated that TasP is effective in reducing infectiousness of the treated person – But much more is required. TasP requires effective.
User Perspective on ARV-Based HIV Prevention Suwat Chariyalertsak, MD., Dr.PH Research Institute for Health Sciences Chiang Mai University.
Know Your epidemic: The value of population-based household surveys Eva Kiwango Senior Strategic Information Advisor United Nations Joint Programme on.
HIV Disease in Older Patients Donna M. Gallagher, ANP The International AIDS Society–USA DM Gallagher, ANP. Presented at IAS–USA/RWCA Clinical Conference,
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Patients in routine HIV clinical care at-risk for potentially transmitting HIV in the “test and treat” era of HIV prevention Crane, HM, Mimiaga, M, Feldman,
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
What does PrEP mean for people living with HIV? Edwin J Bernard Co-ordinator, HIV Justice Network Consultant, GNP+
Creating an AIDS-Free Generation The beginning of the end of AIDS Center for Strategic & International Studies Washington, DC March 22, 2012 Thomas R.
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Center for Health Policy Health Inequalities Program Duke University Beth Stringfield.
ART for Prevention From Evidence to Action Wafaa El-Sadr, MD, MPH ICAP-Columbia University.
Kevin Fenton, MD, PhD National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention August 5, 2008 Update on the US HIV/AIDS Crisis: Current Trends,
Washington D.C., USA, July 2012www.aids2012.org Equal behaviors, unequal risks: The role of partner transmission potential in racial HIV disparities.
High Impact Prevention and the Future of the HIV Epidemic in the United States Jonathan Mermin, MD, MPH Division of HIV and AIDS Prevention, NCHHSTP Centers.
Implementation of HIV Treatment as Prevention in China Yan Zhao MD National Center for AIDS/STD Control & Prevention Chinese Center for Disease Control.
HIV-infected subjects with CD4 350 to 550 cells/mm serodiscordant couples HPTN 052 Study Design Immediate ART CD Delayed ART CD4
How to Avoid a Flood: Practical Advice for Calculating the HIV Treatment Cascade Kathleen A. Brady, MD Medical Director/Medical Epidemiologist AIDS Activities.
STATE OF THE STATE SHELLEY LUCAS HIV/STD PREVENTION & CARE BRANCH DEPT OF STATE HEALTH SERVICES AUGUST 3, 2015.
HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.
AIDS PREVALENCE IN THE WORLD. AIDS EVAPORATES GAINS OF THE 20 TH CENTURY IN AFRICA.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.
‘Gaps in the global HIV/AIDS success story Copenhagen December 2 nd 2013 Gaps in the global HIV/AIDS success story Briefing on HIV/AIDS in Europe Martin.
Multiple and Concurrent Partners: New Insights, New Tools and New Challenges Allison Herling Ruark, MSPH Harvard Center for Population and Development.
Richard Wolitski, PhD Division of HIV/AIDS Prevention Housing and Health : A CDC Perspective July 21, 2012 AIDS 2012 International Housing Summit World.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
High-impact interventions. Number of people living with HIV who were not receiving antiretroviral therapy, 2014 and 2015 Source: UNAIDS estimates, 2014.
1 HIV/STD in Texas Ann Robbins Texas Department of State Health Services June 2009.
The investment framework - Critical enablers are not a luxury! Bernhard Schwartlander.
Michael J. Mugavero, MD, MHSc Associate Professor of Medicine University of Alabama at Birmingham Birmingham, Alabama Elements of the Care Continuum FORMATTED:
Strategies for Management of Antiretroviral Therapy Study Wafaa El-Sadr and James Neaton for the SMART Study Team.
Grinsztejn B, et al, Lancet Infect Dis, March 4 th 2014 PRIMARY COMBINED M&M OUTCOME FIRST AIDS DEFINING EVENT FIRST TB EVENT DEATH.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
HIV Prevention: A Winnable Battle Centers for Disease Control and Prevention.
Henry Masur, MD Bethesda, Maryland
HIV/AIDS in Utah Edwin Espinel HIV Counseling & Testing, Partner Services Program Coordinator University of Utah May 2013 Utah Department of Health Bureau.
Center for Studies of Addiction, University of Pennsylvania, USA
Treatment as prevention: policy and programmatic considerations
Contents - HIV global slides
HPTN 071 (PopART): Have we reached the targets after two years of the PopART intervention IAS Paris July 2017 Richard Hayes.
Number of people receiving antiretroviral therapy in
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
Richard hayes London school of hygiene & Tropical Medicine
WHO HIV update July 2018 Global epidemic Global progress and cascade
Elements of the Care Continuum
Antiretroviral therapy coverage in sub-Saharan Africa,
Contents - HIV global slides
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS Surveillance in Europe
Contents - HIV global slides
Retention: What It Means for You
Contents - HIV global slides
HIV.
Lesson 3: Treatment as Prevention
Robert H. Remien, Co-Chair
Presentation transcript:

Washington D.C., USA, July 2012www.aids2012.org Treatment as Prevention: It is complex: Let us work on it Kenneth H. Mayer Fenway Health Beth Israel Deaconess Hospital Harvard Medical School Boston, Mass July 23 rd, 2012 Session Room 2

Is Treatment as Prevention Utopian?

Percentage of women and men who received an HIV test and test results in last 12 months, 2003–2010 (WHO/UNAIDS) Most PLHIV are unaware that they are infected Successful TasP requires massive ↑Testing

Still a long way to go to reach 15 million on ART, let alone treating everyone Estimated gap: CD4 cell count ≤ 350/mm 3 but not on ART Patients receiving ART 47% 3% WHO, % 97%

Effective prevention interventions have not been brought to scale Goal: ~ 20 million by 2016 Total MCs through 2011: ~1.35 million, 6.5% of target # Source: WHO Male circumcisions performed annually in 14 priority countries in eastern and southern Africa

Major inequities persist in access to treatment and prevention PROPORTION OF PEOPLE WHO INJECT DRUGS RECEIVING ART IN LOW AND MIDDLE INCOME COUNTRIES IN EECA REGION Number of reporting countries among 26 low- and middle-income countries surveyed HIV cases among people who inject drugs (% among cumulative reported HIV cases with a known transmission route) 46,052 (71%) 221,849 (77%) 249,982 (77%) 185,565 (62%) People who inject drugs receiving antiretroviral therapy (% among the total reported people receiving ART with a known route of transmission) 130 (20%) 4,670 (26%) 5,275 (26%) 7,646 (22%) Source: Global HIV/AIDS Response. Epidemic update and health sector progress towards Universal Access. Progress Report WHO/UNAIDS/UNICEF. Table 6.9, p. 137.

Who is Prescribed ART and Who Achieves Viral Suppression in the USA (MMP)? CharacteristicPrescribed ART % (95% CI) Virally suppressed % (95% CI) Race/ethnicity Non-Hispanic White92 (90-94)80 (76-83) Non-Hispanic Black86 (83-88)*64 (60-68)* Hispanic89 (86-92)74 (71-78) Other87 (81-94)69 (63-76) Sexual risk behavior MSM89 (87-91)76 (72-79) MSW91 (88-93)70 (66-75) WSM86 (83-89)66 (62-70)* * P value <0.05 Skarbinski, CROI, 2012

80% 77% 51% 89% 77% MMWR (60), ,000 with HIV do not have virus under control (72%) Clinical Care System Considerations Addressing the HIV Continuum of Care

Early retention in care (Mugavero et al)  The first year in outpatient HIV medical care is a dynamic, formative & vulnerable time  Poor early retention in care associated with:  Delayed / failed antiretroviral therapy (ART) receipt  Delayed time to VL suppression and greater cumulative HIV burden  Increased sexual risk transmission behaviors  Increased risk of clinical events & mortality  Worse ART adherence, CD4 & VL response and increased long-term mortality following ART start Ulett et al. AIDS Pt Care STDS 2009;23, Giordano et al. JAIDS 2003;32, Metsch et al. Clin Infect Dis 2008;47, Mugavero et al. Clin Infect Dis 2009;48, Tripathi et al. AIDS Res Hum Retrovirus 2011;e-pub, Giordano et al. Clin Infect Dis 2007;44

 Outcome: 1 o HIV provider visit attended w/in: Case Management Standard of Care P-value 6 months 78%60%<0.01 Gardner et al. AIDS 2005;19  Intervention is efficacious, but additional steps needed to promote linkage to care… 12 months 64%49%<0.01 Linkage to Care: CDC ARTAS

Clinical Care System Considerations Linkage, retention, and effectiveness (USA) Linkage to care and preventive services – Only 69% of persons with HIV attend clinic within 12 months of diagnosis – Case management improves linkage by 32% at cost of $1,200 per person – Interventions focused on adherence increase likelihood of undetectable viral load by 15% Effectiveness depends on coverage during entire cascade from testing to care – Transmission reductions can vary from 15% to 44% Walensky ClD 2010, Marks AIDS 2010; Crepaz AIDS

Looking Ahead: Challenging Times for HIV Prevention Picture in the United States especially grim: – Federal deficit ~$1.3 trillion for FY 2011 – 5-year freeze on federal discretionary spending – Reductions in HIV prevention by health departments ~45,000 state and local public health jobs lost Staff furloughs, hiring freezes, pay cuts – Many community organizations closed or struggling Similar picture being observed in other Western Industrialized settings, driven by economic downturn *Total includes HIV and viral hepatitis prevention programs, but majority of funds cut were from HIV Kaiser Family Foundation; NASTAD; Center on Budget and Policy Priorities

Social Cognitive Model: TasP Needs to Consider Concomitant Issues Self efficacy Safer Sex Adherence Pleasure reduction Disease prevention Social Models Depression, anxiety, mental health problems Wulfert, Safren, et al., 1999; Journal of Applied Social Psychology

Total HIV-1 Transmission Events: 39 HPTN 052: Lots of “Uncoupled” Transmissions Linked Transmissions: 28 Unlinked or TBD Transmissions: 11 p < Immediate Arm: 1 Delayed Arm: 27 Up to 30% of new infections in couples occur outside the primary relationship (Campbell et al PLoS One 2011; Hughes et al. J Infect Dis 2011)

Source: Tim Hallett, personal communication A combination of interventions has more impact than the interventions delivered alone

16 Decrease in HIV Transmission Decrease in HIV Transmission Maintain Viral Suppression Suppression TreatTreat Enroll in Care Address concomitant concerns, e.g. depression, substance use, relationship dynamics Combination Antiretroviral Prevention HIV Negative TestTest Interventions to Increase Testing PositivePreventionPositivePrevention Linkage To Care Linkage Adherence to ART ART Initiation. Risk Assessment PrEP, Adherence Counseling Counseling HIV Positive

Thank You Kevin Fenton Gottfried Hirnschall Tim Hallett Steven Safren Jacek Skarbinski Michael Mugavero Wafaa El-Sadr NIAID, NIMH, NIDA, NICHD, CDC, HRSA, Mass DPH, Gilead